Navigation Links
ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R)
Date:2/22/2008

nd for the treatment of ocular inflammation and pain. Xibrom, approved in 2005, is the first and only FDA-approved twice-daily NSAID for inflammation and reduction of pain following cataract surgery. Xibrom was the fastest-growing ophthalmic product in 2007, according to IMS data. Xibrom, under a different trade name but identical formulation, was launched in Japan in 2000 by Senju Pharmaceuticals Co. Ltd. ISTA acquired U.S. marketing rights for Xibrom in 2002 and launched the product in the U.S. in 2005.

About Istalol(R)

Istalol is a once-daily, topical solution of timolol, a beta-blocking agent for the treatment of glaucoma. ISTA holds exclusive marketing rights to Istalol in the United States under license from Senju Pharmaceutical Co., Ltd., which developed the product in Japan.

ABOUT ISTA PHARMACEUTICALS

ISTA Pharmaceuticals is an ophthalmic pharmaceutical company. ISTA's products and product candidates addressing the $3.2 billion U.S. prescription ophthalmic industry include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. The Company currently markets three products and is developing a strong product pipeline to fuel future growth and market share. The Company's product development and commercialization strategy is to launch a new product every 12 to 18 months, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' website at http://www.istavision.com.

Forward-Looking Statements

Any statements contained in this press release referring to future events or other non-historical matters are forward-looking statements. Without limiting the foregoing, but by way of example, statements contained in this press release concerning prospects related to the presentation of data at the ARVO 2008 annual meeting, ISTA initiating fu
'/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Memory Pharmaceuticals & Roche Expand Development Program for MEM 3454 in Schizophrenia
2. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
3. Indevus Pharmaceuticals Provides Update on PRO 2000 Program
4. Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial
5. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
6. Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors
7. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
8. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
9. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
10. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
11. Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... -- WuXi PharmaTech (Cayman) Inc. (NYSE:  WX), a leading ... pharmaceutical, biotechnology, and medical device industries with operations in ... United States , congratulates our partner TaiMed Biologics ... for ibalizumab (TMB355). The FDA designates a drug as ... in combination with one or more other drugs, to ...
(Date:2/27/2015)... - La ... monitoraggio dell,infarto congestizio (CHF - Congestive Heart Failure) ...   Vectorious Medical Technologies, società ... il monitoraggio cardiaco destinato a pazienti affetti da ... concluso una raccolta di finanziamenti per 5 milioni ...
(Date:2/27/2015)... Feb. 27, 2015  Boston Scientific Corporation (NYSE: ... Barclays 2015 Annual Healthcare Conference on March 10 in ... Dan Brennan , executive vice president and chief financial ... Relations, will participate in a 25-minute question and answer ... approximately 1:05 p.m. ET. Following a 5-minute break, a ...
Breaking Medicine Technology:WuXi Congratulates TaiMed Biologics on Receiving Breakthrough Therapy Designation from U.S. FDA 2Vectorious Medical Technologies completa una raccolta di 5 milioni di dollari 2Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2
... joined the ranks of a select group.  The 41-bed provider ... one of only 100 hospitals to do so as of ... Health IT Policy Committee, an industry group that works with ... (ONC-HIT). The Jacksboro, Texas-based hospital is leveraging the ...
... 2011 Elekta announced it has received approval ... system in the European Union. Integrity R1.1 combines ... rate (CVDR) and interdigitation capabilities for Elekta,s MLCi2™ ... of delivery techniques -- such as Intensity Modulated ...
Cached Medicine Technology:Faith Community Hospital Joins Meaningful Use Trailblazers 2Faith Community Hospital Joins Meaningful Use Trailblazers 3New Digital Linear Accelerator Control System Demonstrates Treatment Time Savings of Up to 30 Percent 2New Digital Linear Accelerator Control System Demonstrates Treatment Time Savings of Up to 30 Percent 3
(Date:2/28/2015)... Portland, OR (PRWEB) February 28, 2015 ... Duncan Fletcher of Game Change ... and Shannon Leinert about the benefits of athlete development ... underscores some of the unique challenges that athletes face ... on-field and future success. , Fletcher became involved in ...
(Date:2/28/2015)... March—also known as National Brain ... ourselves and others that suspected head injuries, especially ... (ANS). , Concussions are a form of traumatic ... TBIs. There are 1.6-3.8 million sports-related concussions per ... it is a brain injury. Many athletes suffer ...
(Date:2/28/2015)... For those people who are unable to ... Applied Research Foundation (Meso Foundation) will broadcast its ... at 9:30 AM. , The live broadcast is free ... be accessed through any browser on a computer or ... is a unique event that covers important treatment information ...
(Date:2/28/2015)... India Network Foundation, a ... insurance programs for visitors coming to the United States ... traveling to the United States are suffering from one ... pressure. These diseases are so common among the elderly ... medical conditions. There were 66.8 million cases of diabetes ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 The noted ... announce that they have officially relaunched their website. The ... user-friendly, but it contains a new section about their ... to read the full biographies of each Friedman Dental ... of the website was designed to provide our patients ...
Breaking Medicine News(10 mins):Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3Health News:Friedman Dental Group Announces Their Updated Website 2
... The Crossings, the Texas Hill Country spa retreat, just ... Day for each day booked. From March 8 ... three healthy gourmet meals, gracious and comfortable accommodations with beautiful ... day. In addition, The Crossings offers a heated infinity ...
... Versus Technology,Inc. ("Versus" or the "Company") (OTC Pink ... ended January 31, 2009, a 13% increase over,revenues of ... growth in revenue is,attributable, in part, to more than ... service revenues. Versus, quarterly revenues can vary,significantly depending ...
... listed No. 1 in Health Care: Pharmacy and Other Services ... management worldwideFRANKLIN LAKES, N.J., March 6 Medco Health Solutions, ... position within the Health Care: Pharmacy and Other Services sector ... In addition, of all companies surveyed globally, Medco was ranked ...
... minorities than whites meet criteria for cutting-edge treatment , , ... Hispanic Medicare recipients suffer severe heart failure, they are ... with the most cutting-edge treatment available, a new analysis ... modest differences between racial and ethnic groups in the ...
... Today World Lung Foundation and the American Cancer Society ... online version of the document at TobaccoAtlas.org. This comprehensive ... how tobacco is devastating both global health and economies. ... Economy , According to The Tobacco Atlas, tobacco,s ...
... release is available in German . , ... in the treatment of certain brain tumours. This has been ... German and Swiss colleagues in a current study. They treated ... The patients survived on average 23 months; with the standard ...
Cached Medicine News:Health News:A Massage A Day at The Crossings 2Health News:Versus Technology Announces First Quarter Results 2Health News:Versus Technology Announces First Quarter Results 3Health News:Versus Technology Announces First Quarter Results 4Health News:Versus Technology Announces First Quarter Results 5Health News:Versus Technology Announces First Quarter Results 6Health News:Medco Tops Fortune's Lists of 'World's Most Admired' Companies 2Health News:Medco Tops Fortune's Lists of 'World's Most Admired' Companies 3Health News:Blacks, Hispanics Less Apt to Get Best Heart Failure Care 2Health News:Blacks, Hispanics Less Apt to Get Best Heart Failure Care 3Health News:New edition of the Tobacco Atlas catalogues catastrophic toll of tobacco worldwide 2Health News:New edition of the Tobacco Atlas catalogues catastrophic toll of tobacco worldwide 3Health News:Brain tumors: New therapy surprisingly successful 2
The Restoration GAP system addresses complex acetabular reconstruction with morselized graft through immobilization and proper compressive loading, the two mechanical factors influencing the integrat...
The MPF cup is specifically designed to achieve high primary stability, a critical factor for long term success....
Performa uncemented stem....
Porous foundation 480 series....
Medicine Products: